Abstract:BackgroundNARS2 catalyzes the attachment of asparagine amino acids to mitochondrial tRNAAsn and is critical for efficient mitochondrial protein synthesis. Biallelic variants in NARS2 are associated with combined oxidative phosphorylation deficiency 24 (COXPD24) and autosomal recessive deafness-94.MethodsPatient information was obtained after recruitment. Genetic tests were performed using whole exome sequencing (WES) and Sanger sequencing. Structure prediction was based on the RaptorX and SWISS-MODEL platforms. The mRNA analysis of paternal variant was performed. Expression levels and dimerization of wild-type (WT) and mutant NARS2 were detected in human embryonic kidney (HEK) 293T cells. Mitochondrial localization of NARS2 variants was determined using immunofluorescence staining.ResultsThe patient presented early onset generalized epilepsy, myoclonic seizures, severe bilateral hearing impairment and affected liver and heart. WES identified two compound heterozygous variants in NARS2: c.1141A>G/p.Asn381Asp and c.1290G>C/p.Trp430Cys. In silico analysis predicted that both variants would cause significant and pathogenic changes in secondary structure. NARS2 c.1290G>C is a variant at the first nucleotide of an exon, a location thought to affect mRNA splicing. Although transcriptional experiments did not identify aberrant splicing, we observed a lower proportion of transcripts from the NARS2 c.1290G>C variant. An in vitro experiment showed that both variants impaired NARS2 expression, while mitochondrial localization and dimerization remained unaffected.ConclusionsThe patient was diagnosed with COXPD24 caused by novel NARS2 variations. The cardiac dysfunction is identified for the first time. In vitro study revealed impairment of variants on NARS2 expression. These data enrich our knowledge regarding the phenotypic and genotypic spectra of NARS2.

Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review

Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-Trna Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome

Study of Novel NARS2 Variants in Patient of Combined Oxidative Phosphorylation Deficiency 24

Early-onset dysphagia and severe neurodevelopmental disorder as early signs in a patient with two novel variants in NARS1: a case report and brief review of the literature

NOTCH2NLC-related Repeat Expansion Disorders: an Expanding Group of Neurodegenerative Disorders

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

Novel NARS2 variant causing leigh syndrome with normal lactate levels

FARS2 Deficiency in Drosophila Reveals the Developmental Delay and Seizure Manifested by Aberrant Mitochondrial Trna Metabolism.

Bilateral Nonsyndromic Sensorineural Hearing Loss Caused by a NARS2 Mutation

Aminoacyl‐tRNA synthetase defects in neurological diseases

Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview

A Term Neonate with Early Myoclonic Encephalopathy Caused by RARS2 Gene Variants: a Case Report.

An intractable epilepsy phenotype of ASNS novel mutation in two patients with asparagine synthase deficiency

Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy

The role of tRNA synthetases in neurological and neuromuscular disorders

Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report

Expanded phenotype of AARS1-related white matter disease

Alanyl-transfer ribonucleic acid synthetase 2 gene mutation producing leukodystrophy: a case report

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

Mitochondrial aminoacyl-tRNA synthetases trigger unique compensatory mechanisms in neurons

Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy